AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 100 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $199,000 | -92.2% | 19,900 | -82.5% | 0.00% | -90.5% |
Q1 2017 | $2,564,000 | +7.2% | 113,703 | +65.4% | 0.02% | 0.0% |
Q4 2016 | $2,392,000 | +270.3% | 68,742 | +161.0% | 0.02% | +250.0% |
Q3 2016 | $646,000 | +30.2% | 26,342 | +27.1% | 0.01% | +20.0% |
Q2 2016 | $496,000 | +11.0% | 20,733 | +8.5% | 0.01% | +25.0% |
Q1 2016 | $447,000 | -9.1% | 19,111 | +17.2% | 0.00% | -20.0% |
Q4 2015 | $492,000 | +98.4% | 16,300 | +36.1% | 0.01% | +66.7% |
Q2 2014 | $248,000 | – | 11,975 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |